DANIEL L KISNER
CIK 1073407 · last filed 2026-02-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
68
Lifetime Open-Market Net
-$215.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Director | 15,000 | $15.50 | $232.5K | $10.8K | 20 | 2026-02-10 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | 10,000 | $0.53 | $5.3K | $23.8K | 9 | 2024-06-24 |
| Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Director | 47,824 | $1.30 | $62.2K | -$80 | 10 | 2023-10-11 |
| Histogen Inc. (HSTO) Delisted | Director | — | $0.21 | — | $0 | 4 | 2023-06-21 |
| Histogen Inc. (CNAT) Delisted | Director | 7,145 | — | — | $23.0K | 10 | 2019-07-01 |
| Apollo Endosurgery, Inc. (LPTN) Delisted | Director | — | — | — | $0 | 4 | 2016-02-18 |
| CALIPER LIFE SCIENCES INC (CALPW) Delisted | Director | 109,301 | — | — | -$272.7K | 10 | 2008-06-05 |
Recent Filings · Page 2 of 7
68 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-16 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | +23,069 | -$40 | EDGAR |
| 2022-06-03 | Histogen Inc. (HSTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-03 | Histogen Inc. (HSTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-05 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2021-06-02 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-27 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-09 | Histogen Inc. (HSTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-31 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-31 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.